HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 12, December 2021 – The Future of Us — Transforming Healthcare With Intelligent Machines       » Better Targeted Leukaemia Treatment With New Ferritin-Based Nanomedicine       » Manufacturing Chiral Medicine With New Cobalt-Based Catalyst       » SMART Develops 10-Minute Test for Detection of COVID Immunity       » From Plastics to Plants: Transforming Bio-Based Polymers into Fertilisers       » Creating Solar Cells and Glass From Wood and a Billion Tons of Biowaste      
Vol 25, No. 11, November 2021   |   Issue PDF view/purchase
INSIDE INDUSTRY
A Singapore-Based HealthTech Startup Redefines Chronic Disease Care With Promising Clinic Acquisition
HeartVoice, a Joint Venture between Omron Healthcare and iAPPS Pte Ltd aims to pre-empt and eradicate chronic diseases by transforming the traditional healthcare space.

A HealthTech start-up, HeartVoice announced its acquisition of Integrated Wellness Clinic in Novena Specialist Center. The clinic has been offering Health Screening services for corporate clients since 2015, pioneering this field, having served over 600 corporate clients and 45,000 patients. Combining its strong technological capabilities with the medical expertise of the acquired clinic, HeartVoice has formed a new entity called i-Wellness@HeartVoice to provide preventive healthcare solutions that go beyond prescribing medication.

As a Joint Venture between OMRON Healthcare and iAPPS Pte Ltd., HeartVoice offers a full suite of MedTech solutions to help individuals and corporates achieve better health outcomes through preventive healthcare services, powered by digital transformation technology.

“Through this acquisition, our team has become stronger with the addition of a medical arm consisting of family physicians, qualified nurses and sophisticated patient service officers (ex-SQ chief crew to set exemplary customer service standards at the clinic). The entire HeartVoice team is now backed by a strong advisory board under iAPPS Health Group, led by its chairman Dr. Lam Pin Min, former Senior Minister of State for Health,” said Mr Daisuke Nozaki, Managing Director, HeartVoice Pte. Ltd.

Tackling Chronic Diseases One Office At A Time  

HeartVoice’s redefined solution for corporate clients involves one-to-one, personalised care, where every patient’s journey starts with a corporate health screening. Depending on individual results, employees will be then referred to diabetes or cardiology specialists on HeartVoice’s medical board or recommended to enrol into one of the Health Programmes that focuses on Hypertension, Hyperlipidaemia, Diabetes, or Obesity.

Every health programme includes a Remote Patient Monitoring module that is developed based on Omron’s monitoring dashboard and Bluetooth-enabled medical devices. This allows patients to monitor their health vitals at home and share their readings directly with i-Wellness@HeartVoice doctors for prompt and frequent follow-ups.

To facilitate patients’ behavioural changes towards weight loss and diabetes control, HeartVoice offers nBuddy, a lifestyle management mobile app. Backed by clinical studies and scientific evidence and conceptualised by NUH Chief Dietitian Dr. Lim Su Lin, nBuddy is proven to be effective in promoting positive lifestyle changes, as reported in four peer-reviewed journals.

HeartVoice’s approach to healthcare is designed to guide patients through each step of their wellness journey, having all features integrated on a single platform for doctor’s and patient’s convenience.

To help other clinics with digital transformation, HeartVoice has managed to secure financial aid under IMDA (Infocomm Media Development Authority) scheme for PSG grant and Skills Future Enterprise Credit (SFEC). Up to date, more than 30 GP and specialist clinics have joined HeartVoice network to provide telemedicine, remote patient monitoring and home-based monitoring services to their patients.

Servicing the Community in the Time of COVID-19

In June 2021, HeartVoice’s clinic has been appointed by Singapore’s Ministry of Health (“MOH”) as one of 31 private clinics to administer the Sinovac COVID-19 vaccine. Supported by a dedicated team equipped with medical and technological knowledge, the clinic was able to administer full doses of vaccination to more than 4,000 patients. Following its first vaccination drive which was completed in August, HeartVoice has also been approved to provide Singapore residents with Pre-departure polymerase chain reaction (PCR) Swab Test and The Serology Antibody Test for COVID-19.

As further plans for expansion are in the works, the HeartVoice team is not planning to stop anytime soon. As of September 2021, the clinic has already started its second Sinovac Vaccination drive, and was recently appointed by MOH as one of the telemedicine providers for Home Recovery Programme to aid Singapore residents to safely recover from Covid-19 in the comfort of their homes.


Source: HeartVoice Pte Ltd

NEWS CRUNCH  
news Inaugural Asia Summit on Global Health highlights Hong Kong's advantages
news Asia Summit on Global Health (ASGH) 2021 — Shaping a Resilient and Sustainable Future
news TechInnovation 2021 Virtual Exhibition to Showcase Sustainable Energy, Food, and Healthcare Solutions
news A New Approach for Effective Gout Treatment
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Carmen Chan
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy